284 results
Stent loss and coronary perforation: how to deal with
16 May 2024 – From EuroPCR 2024
This session explores the management of challenging complications during percutaneous coronary interventions, such as stent loss and coronary perforation. The presenters share case studies that demonstrate various techniques and strategies used to address these complications, including the use of CTO wires for distal wire perforation, managing...
Acute coronary syndrome caused by coronary aneurysms
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary artery aneurysms. Participants will learn about the diagnosis, management, and treatment strategies for these rare and complex cases, including the use of imaging and interventional techniques to address the underlying pathology.
Acute coronary syndromes due to coronary dissection
16 May 2024 – From EuroPCR 2024
This session will explore various cases of acute coronary syndromes caused by coronary dissection. Participants will learn about the diagnosis, management, and treatment strategies for spontaneous coronary artery dissection, including the use of imaging and interventional techniques to address these challenging cases.
How to solve tricky coronary complications
16 May 2024 – From EuroPCR 2024
From balloon rupture during double-kissing crush stenting to a successful bailout for delayed coronary obstruction post-TAVI, and an unforeseen complication after chimney stenting in a high-risk patient, the session covers it all. Learn about the nuclear mushroom phenomenon during PCI in a calcified LAD, strategies for...
Cracking open the discussion on the clinical experience with intravascular lithotripsy in acute coronary syndromes
16 May 2024 – From EuroPCR 2024
Explore this session to uncover the common association between calcium and acute coronary syndrome, and how intravascular lithotripsy (IVL) offers a safe solution for calcified lesions, with comparable procedural success rates. However, note that ACS cases involving calcium may lead to higher major adverse cardiac events...
Complex PCI in NSTEMI - Part 1
15 May 2024 – From EuroPCR 2024
This session features selected EuroPCR 2024 Clinical Case submissions focused on complex percutaneous coronary interventions (PCI) in patients with non-ST-elevation myocardial infarction (NSTEMI). Experts will present and discuss challenging cases, including scenarios involving bleeding risks, wandering coronary stents, and the use of intravascular ultrasound (IVUS) guidance...
Complex scenarios beyond complex interventions, time to take multiple factors into account
15 May 2024 – From EuroPCR 2024
NSTEMI in patients in post CABG: a challenging combination
15 May 2024 – From EuroPCR 2024
This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...
An image is worth a 1,000 words
15 May 2024 – From EuroPCR 2024
Randomised trials: substudies and extended follow-up - A quick update
15 May 2024 – From EuroPCR 2024
This session provides a quick update on various randomised trials, including substudies and extended follow-up data. It covers insights on bifurcation stenting, the symptom-stratified analysis of ORBITA-2, the impact of completeness of revascularisation on clinical outcomes from REVIVED-BCIS2, cost-effectiveness of CABG vs. PCI from FAME 3,...
Artificial intelligence-powered quantification of coronary physiology and vulnerable plaque: opportunities for novel treatment options
15 May 2024 – From EuroPCR 2024
In this session, uncover new data on Murray-law based quantitative flow ratio (muFR) assessment, providing a comprehensive understanding of PCI outcomes from a single angiographic view, explore the innovative application of artificial intelligence in identifying vulnerable plaque and assessing hemodynamic stenosis significance through the analysis of...
Targeting inflammation in AMI: a debate
14 May 2024 – From EuroPCR 2024
Watch this session to explore inflammation's role in AMI, from atherosclerosis to post-infarct remodeling. Find out more about IL-6's significance in future MACE risk and cardiac status deterioration post-AMI, and delve into targeting inflammation via IL-6, evaluating short and long-term impacts.
Mechanical circulatory support in cardiogenic shock and high-risk PCI
14 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on the use of mechanical circulatory support in cardiogenic shock and high-risk PCI. It includes presentations and discussions on lowering cardiogenic shock mortality through a comprehensive mechanical circulatory support approach, the use of lactate and lactate clearance...
Hotline: advances in coronary physiology
14 May 2024 – From EuroPCR 2024
This hotline session explores the latest advancements in coronary physiology and their implications for percutaneous coronary intervention (PCI). Topics covered include the influence of pathophysiological patterns of coronary artery disease on the safety and efficacy of PCI, the prognostic value of myocardial ischemic burden in STEMI...
Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial
07 Apr 2024
REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.
Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...
Author
Author
One-month ticagrelor monotherapy after PCI in acute coronary syndromes: Principal results from the double-blind, placebo-controlled Ultimate DAPT trial
07 Apr 2024
Elad Asher provides his take on the ULTIMATE-DAPT Trial results which Gregg W Stone presented at ACC.24 in Atlanta.
Author
PCRonline @ ACC.24 Scientific Sessions
22 Mar 2024
Live updates on a selection of major Late Breaking Clinical Trials of interest in interventional cardiology presented at the American College of Cardiology 2024 Scientific Sessions #ACC24
Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in acute coronary syndromes: The multicenter, randomized, blinded, IVUS-ACS Trial
09 Apr 2024
Marco Spagnolo and Daniele Giacoppo report the main results of the IVUS-ACS trial presented by Shao-Liang Chen, from the Nanjing First Hospital, Nanjing Medical University, Nanjing, in a Featured Clinical Research session at ACC.24 in Atlanta and simultaneously published in The Lancet.(1)
Author
Author
Medically treated nonischemic thin-cap fibroatheroma lesions versus fractional flow reserve-guided complete revascularization in diabetic patients
27 Feb 2024
This sub-analysis denotes that medically treated diabetic patients with FFR-negative, TCFA-carrying target lesions were associated with a higher rate event rate compared to angiographically similar ischemic target lesions that underwent revascularization.
Reviewer
A stuck Rota burr in a "flintstone" coronary artery
18 Dec 2023
Step by Step video on how to deal with a stuck Rota burr with the same arterial access. Nice example of Kokeshi phenomenon.
Author
Author
